China Financial Statements From 2010 to 2025

600511 Stock   31.92  0.11  0.35%   
China National financial statements provide useful quarterly and yearly information to potential China National Medicines investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on China National financial statements helps investors assess China National's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting China National's valuation are summarized below:
China National Medicines does not presently have any fundamental signals for analysis.
Check China National financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among China National's main balance sheet or income statement drivers, such as , as well as many indicators such as . China financial statements analysis is a perfect complement when working with China National Valuation or Volatility modules.
  
This module can also supplement various China National Technical models . Check out the analysis of China National Correlation against competitors.

China National Medicines Company Current Valuation Analysis

China National's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current China National Current Valuation

    
  16.45 B  
Most of China National's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, China National Medicines is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, China National Medicines has a Current Valuation of 16.45 B. This is much higher than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The current valuation for all China stocks is notably lower than that of the firm.

China National Medicines Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining China National's current stock value. Our valuation model uses many indicators to compare China National value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across China National competition to find correlations between indicators driving China National's intrinsic value. More Info.
China National Medicines is rated third in return on equity category among its peers. It also is rated third in return on asset category among its peers reporting about  0.33  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for China National Medicines is roughly  3.03 . Comparative valuation analysis is a catch-all model that can be used if you cannot value China National by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for China National's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

About China National Financial Statements

China National stakeholders use historical fundamental indicators, such as China National's revenue or net income, to determine how well the company is positioned to perform in the future. Although China National investors may analyze each financial statement separately, they are all interrelated. For example, changes in China National's assets and liabilities are reflected in the revenues and expenses on China National's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in China National Medicines. Please read more on our technical analysis and fundamental analysis pages.

Currently Active Assets on Macroaxis

Other Information on Investing in China Stock

China National financial ratios help investors to determine whether China Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in China with respect to the benefits of owning China National security.